450 mL of blood, whereas B-Hb concentration was only returned to baseline after 4 weeks. 7 The above studies were primarily performed in men and given the differences in circulating blood volume, Hb concentration, hematocrit (Hct), and hormone levels there may well be a sex difference in the effect of blood donation on physical performance, and more importantly the recovery after blood donation might not be the same in women as in men. 8 In addition to the basic physiologic sex differences there is also a high prevalence of iron deficiency in premenopausal women, physically active women, and women donating blood, [9] [10] [11] which further substantiates the importance of studying women. Therefore, the purpose of this study was to examine the influence of a standard 450-mL blood donation on physical performance measured as VO 2peak and TT and subsequent recovery in physically active women. Blood variables (B-Hb, Hct, and plasma-ferritin [P-ferritin]), plasma erythropoietin (P-EPO) concentration and plasma 2,3-diphosphoglycerate (P-2,3-DPG) concentration were measured to elucidate the hematologic changes and hormonal fluctuations caused by blood donation and their potential coupling to the physical performance. Based on the prior studies our hypothesis was that TT performance and peak VO 2 would be back to baseline after 14 days and B-Hb concentration after 28 days in iron-sufficient premenopausal women similar to that observed for men.
MATERIALS AND METHODS

Subjects
Twenty healthy women volunteered to participate in the study. All subjects were informed about the possible risks and discomfort involved before written consent to participate was obtained. The study was performed according to the Declaration of Helsinki and was approved by the Ethical Committee of Copenhagen (H4-2011-097)
The subjects were recruited through blood donor registers for both Hvidovre and Frederiksberg Hospital or made contact themselves based on a poster at motioensloeb.dk and at other relevant places. Inclusion criteria were as follows: active blood donor, regular running activity a minimum of two times per week, no diagnosed cardiovascular disease, age 20 to 45 years, normal plasma ferritin (P-ferritin) status of more than 30 mg/L, body mass index from 18 to 30 kg/m 2 , and no use of medication affecting physical performance or bloodletting. Oral contraceptives and intrauterine contraceptive devices were allowed compatible with the Danish blood donor regulations. 12 To ensure a normal P-ferritin before the study the women received iron supplementation, which consisted either of Ferrofumarat (100 mg/60 mg) or of Ferrochel Bisglycinate (ferrochel 25 mg) or a combination of both depending on their baseline P-ferritin value. Despite the supplementation two subjects presented with iron depletion (P-ferritin 12-20 mg/L) and they were excluded from the study. The two women were similar in anthropometric characteristics and performance and maximal oxygen uptake variables at baseline.
Before the experiment the 3-km TT was validated by eight physically active female subjects (height 172 6 3 cm, weight 62.8 6 2.8 kg, age 29 6 2 years, range 24-40 years). Each subject was tested three times spaced at least 2 days apart (raw data not included). The validation yielded a coefficient of variance of 1.1%.
Experimental protocol
Before enrollment in the study, participants were screened for pulmonary and cardiovascular abnormalities and other conditions that could complicate the physical tests. At the interview it was emphasized that subjects during the experimental period should maintain their habitual lifestyle in regard to physical activity and nutrition, to maintain training status. If contraception was used, type and name were registered. Furthermore, the subjects were told to give notice when they were menstruating and for how long.
Before the blood donation a bicycle VO 2peak test and a 3-km treadmill TT were performed on 2 separate days for customization to the protocol. After the bloodletting the same tests were repeated on Days 3, 7, 14, 21, and 28 ( Fig. 1) .
On the experimental days subjects came to the laboratory during the day. After 10 minutes of rest in the supine upright, sitting position a venous blood sample was obtained. After this a VO 2peak test was performed on a bicycle ergometer (Ergo metrics 800, Jaeger) and pulmonary oxygen uptake, carbon dioxide excretion, and ventilation were measured using an online system (Jaeger Oxycon Pro, Viasys Healthcare). The VO 2peak protocol consisted of a 5-minute workload at 75 W followed by incremental workload addition of 25 W every minute until the subject was unable to sustain pedaling. Criteria for VO 2peak were leveling off, respiratory exchange ratio of more than 1.1, and marked hyperventilation. Time until achieving VO 2peak was recorded as an additional measure of endurance performance. VO 2peak was determined as the highest value over 30 seconds in a rolling average using three consecutive 10-second periods.
After the VO 2peak test subjects rested for 30 minutes in the sitting position and had free access to water. After this, subjects completed a 5-minute warm-up at a selfselected pace on a treadmill (Wood Way XL pro WOOD-WAY Gmbh). After this a self-paced 3-km treadmill TT was performed, where subjects were asked to complete the distance as fast as possible. Before the TT, subjects were advised how to perform an optimal TT. The subjects were verbally encouraged during the entire test and the rate of perceived exertion was measured every 500 meters using the Borg scale 13 to secure a score of 17 before 1 1 =2 km. At the same time heart rate was registered. During the TT subjects were blinded for time and speed, leaving heart rate and distance uncovered as the only visible variables during the test. Body composition was assessed at baseline and on Day 28 using dual-energy X-ray absorptiometry (GE Lunar IDEXA). The dual-energy X-ray absorptiometry scanner was calibrated daily with a body composition phantom.
Thirty-five days after blood donation the subjects performed a treadmill VO 2max test. The protocol consisted of a 5-minute warm-up, followed by an incremental speed addition of 1 km/hr every minute for 2 minutes until reaching an individually determined speed calculated as 80% of the subject's mean pace on her fastest 3-km TT. Hereafter a 1% incline was added every minute until exhaustion.
As part of the normal blood donor enrollment most donors are asked to donate blood at intervals of 90 days. Therefore, as part of the donor's normal schedule, we have access to a P-ferritin values 3 months after the initial blood donation. After the experiment and until after the blood donation all the subjects declared not to have taken any iron supplementation.
Blood samples and analytical procedures
The blood samples were obtained from an antecubital vein and were sampled anaerobically and distributed into tubes containing heparin, EDTA, trasylol-EDTA, or lithium heparin. The heparinized samples were immediately analyzed for B-Hb, oxygen saturation, blood pH, CO 2 , O 2 tension, lactate, and Hct (ABL 815 Flex, Radiometer).
For hematologic profiling the EDTA tubes were kept cold and immediately sent to the clinical biochemical department at Hvidovre Hospital, Copenhagen, and analyzed on a hematology analyzer (XE 5000, Sysmex). This apparatus applies hydrodynamic focusing direct current detection method for red blood cell (RBC) count, platelet count, and Hct measurements; a spectrophotometric detection method for Hb measurements; and a flow cytometry method for white blood cell (WBC) count and differentiation. Plasma for the measurement of iron status (P-ferritin) was sampled in lithium heparinized tubes, which were centrifuged at 2480 3 g and stored on ice before delivery to the clinical biochemical department of Hvidovre Hospital for analysis.
Tubes for P-EPO and P-2,3-DPG were centrifuged at 2000 to 2480 3 g and immediately after this procedure plasma was frozen for later analysis at 2808C. Both EPO and 2,3-DPG were measured using high-sensitivity enzyme-linked immunosorbent assay (ELISA) kits. For EPO an ELISA kit was used (Quantikine IVD, R&D Systems). 2,3-DPG was measured using a human 2,3-DPG ELISA kit (CUSABIO). Plasma hepcidin was measured by an ELISA kit (DRG Instruments GmbH). In all cases blood sampling and analytical procedures followed the guidelines of the manufacturers.
Statistical analysis
The statistics were calculated using computer software (SigmaPLOT, Version 11.0, Systat Software, Inc.). To assess changes after blood donation a one-way repeated-measures ANOVA with time as the factor was performed. Multiple post hoc comparisons versus baseline and Day 3 were made using the Holm-Sidak method. In all cases, a p value of less than 0.05 was taken as the level of Fig. 1 . Study design. VO 2peak measured using an incremental bicycle test and TT performance measured using a 3-km blinded TT treadmill run were performed by 18 healthy iron-sufficient women at baseline and 3, 7, 14, 21, and 28 days after blood donation.
DXA 5 dual-energy X-ray absorptiometry scanning.
significance. Results are given as mean 6 SEM if not otherwise stated.
RESULTS
Subject characteristics at baseline
Throughout the study period body weight and lean body mass remained unchanged, whereas a small decrease in body fat from baseline to Day 28 was observed ( Table 1 ). All women menstruated once during the study period and not within the first week of the study.
Oxygen uptake and TT performance
Three days after blood donation the VO 2peak was reduced by 7.5 6 1.1% and it remained lower than baseline until 28 days in (Fig. 2A) . The absolute VO 2peak determined on the treadmill 35 days after blood donation was 3175 6 95 mL/min and thus 8.3 6 1.1% higher (p < 0.01) than the bicycle VO 2peak (2901 6 77 mL/min) determined on Day 28. In the determination of VO 2peak leveling off was achieved in approximately 50% of the tests, but the respiratory exchange ratio exceeded 1.1 in all except for two tests and in all tests marked secondary hyperventilation was achieved.
Mean TT performance was attenuated by 5.2 6 1.0% on Day 3, but was similar (p 5 0.12) to baseline values already 14 days after blood donation (Fig. 2B) . A secondary measure of endurance performance was obtained from the VO 2max test as the time until achieving maximum. From baseline (732 6 18 sec) to Day 3 (699 6 18) it was reduced (p < 0.05) by 4.8 6 0.7%. After 14 days' time until to maximum was not significantly different from baseline (719 6 16 sec).
Blood variables
Three days after the blood donation B-Hb was reduced by 7.6 6 2.1% and it remained lower until the blood sample after 28 days (Fig. 2C) . Three days after blood donation Pferritin was not significantly reduced (p 5 0.18) from baseline (Fig. 3) . After 7 days the P-ferritin had declined and it reached a nadir on Day 28 (55 6 4% lower) compared to baseline. At 90 days P-ferritin was still reduced by 34 6 6% compared to baseline.
The Hct was reduced by 9 6 2% 3 days after blood donation and was back to baseline values after 14 days, although a trend was noted toward lower (p 5 0.06) Hct ( Table 2 ). Seven days after blood donation plasma iron (Piron) was reduced by 41 6 16% and P-iron remained lower than baseline also after 14 days, but not 21 days (Table 2) . Three days after blood donation P-EPO concentration was increased by 40 6 6% and it reached a maximum 14 days after blood donation ( Table 2) . P-EPO remained elevated until the blood sample at 28 days, where only a trend (p 5 0.1) toward higher values was observed ( Table 2 ). The 2,3-DPG concentrations were not significantly affected by blood donation ( Table 2 ). The reticulocyte count peaked 7 days after blood donation 29 6 11% higher compared to baseline ( Table 2 ). The reticulocyte count remained elevated after 14 days, but had returned to baseline after 21 days ( Table 2 ). The RBC count was decreased by 8 6 2% 3 days after blood donation (p < 0.001), but was similar to baseline again after 14 days ( Table 2) .
The mean corpuscular volume and the mean corpuscular Hb concentration were not changed by the blood donation (Table 2) . Similarly the WBC count, the plasma hepcidin content, and the plasma high-sensitivity C-reactive protein (hsCRP) content remained unchanged in response to blood donation (Table 2) .
DISCUSSION
In this study a main finding was that in iron-sufficient women B-Hb concentration and VO 2peak were not back to baseline before 28 days after blood donation, whereas TT performance was returned to baseline values after 14 days. Interestingly P-ferritin remained decreased after 28 days and remained markedly lower than baseline 90 days after blood donation.
It is broadly accepted that maximal oxygen uptake and endurance performance is closely correlated to the oxygen-carrying capacity of the blood. [1] [2] [3] [4] [5] [6] 14 In line with this we observed that peak oxygen uptake and B-Hb concentration remained below baseline until 28 days after the blood donation, which is in contrast to our hypothesis, and former published data in men, 7 that this would be back to baseline after 14 days. Although it failed to reach significance the B-Hb concentration was 3.6 6 1.6% (p < 0.08) and VO 2peak 2.2 6 1.0% (p < 0.08) numerically lower after 28 days compared to baseline, suggesting that these values were only just back to baseline after 28 days.
After the blood donation P-EPO was increased and remained elevated almost throughout the period and thus thereby mirrors the observed lower B-Hb concentration. The blood reticulocytes were elevated already on Day 3 and remained elevated until 21 days after blood donation whereas the blood RBCs were only slightly decreased on Days 3 and 7. In contrast P-ferritin was decreased at 7 days and at a nadir after 28 days, and P-iron decreased after Days 7 and 14. It is thus possible that the reticulocytosis from Day 21 and onward did not remain elevated due to the low P-ferritin and therefore lack of building Hct (%) 40.5 6 0.6 37.3 6 0.7 † 37.4 6 0.6 † 38.9 6 0.5 Because of smaller body size, blood volume, B-Hb concentration, and cardiac output in combination with higher body fat percentage women in general have lower VO 2max than their male counterparts. 8 Even when scaled for body mass or fat-free body mass a difference of more than 5 mL/kg in blood volume is still present, which is attributable to a lower RBC mass in females. Since the venesectioned volume for a blood donation equals 450 mL regardless of sex, it is likely that a blood donation reduces the VO 2peak more in women because of the larger reduction in the oxygen-carrying capacity of the blood. In this study a 7.5 6 1.1% reduction in VO 2peak was found 3 days after blood donation. Similar studies done in men found reductions in maximal oxygen uptake between 5.5 and 10%. 4, 5, 7, 14 However, in the studies done by Ekblom and coworkers 4 and Balke and coworkers 14 these reductions were seen within 1 day after venesection. Plasma expansion is known to take 24 to 48 hours, 15 and the observed reduction could therefore be due both to a lower circulating volume and to filling of the heart as well as due to a reduction in the oxygen-carrying capacity of the blood. In this study the first test was performed after 3 days to ensure that hemodilution had occurred, so the observed reduction would primarily be because of a reduction in the oxygen-carrying capacity of the blood. However, it should be noted that the blood volume after hemodilution is 4% to 6% lower and there may be an effect of decreased venous return and filling pressure that could also contribute to the observations. 15, 16 Based on the relationship between the relative changes in Hb and the change in VO 2peak reported by Calbet and coworkers, 2 the observed reduction in VO 2peak in this study is also caused (20%-30%) by lower blood volume. It is interesting that despite the sex differences mentioned above, we observe a similar reduction in VO 2peak in women compared to studies done in men. However, it has been demonstrated that women aged between 20 and 40 years have a 2 mmol/g Hb higher 2,3-DPG concentration than matched males of similar age, 17 and this induces a rightward shift of the oxygen dissociation curve, which gives a better tissue oxygen delivery. However, caution is required since some evidence implies that the rightward shift, the Bohr effect, may only play a limited role here during higher intensity exercise. 18 Another explanation may be that due to monthly blood loss women have a RBC age distribution that is 80% younger than in men, 19 which allows the RBCs to pass more easily through the smaller capillaries. It is thus likely that this difference in RBC age and possibly 2,3-DPG concentration between women and men contributes to the finding of a similar reduction in VO 2peak . TT was recovered 14 days after blood donation whereas VO 2peak was not fully recovered until after 28 days.
Christensen and Christensen 3 found that maximal work was returned to baseline 14 days after and VO 2max back to baseline 16 days after loss of 1 L of blood. In a study in men using a similar protocol we found a 6.5% reduction in VO 2peak and 5.2% in TT attenuation with both variables being back to baseline on Day 14. 7 Based on the findings of this study compared to prior studies done in men, and in particular our own study 7 applying identical protocols, test equipment, and blood analysis, the recovery of VO 2peak seems to take longer in women than in men after blood donation. Because men do not menstruate, get pregnant, and give birth, they are known to have higher body iron stores than women. 20 With the important role of iron in mitochondrial enzymes this sex difference may be one of the explanations to the faster recovery of VO 2peak after blood donation in men compared to women. In this study we did not start the experiment at the same time in the menstrual cycle, but we did avoid the women having menstruation in the first week. Overall there is no general agreement whether performance in women is influenced or not by the timing in relation to the phase of the menstrual cycle 21,22 and we consider the impact of this on TT performance to be negligible. One major factor that influences iron stores is menstruation. The mean monthly blood loss in association with menstruation is estimated to be approximately 60 mL. 23 The blood loss is affected by the type of contraception, which is reflected in ferritin being higher in women using oral contraceptives than in those using intrauterine devices 24 and in this study only two of 18 women had intrauterine devices. Being a female athlete also seems to be a risk factor toward low iron status. Brown and colleagues 9 observed that 32 female track athletes had significantly lower serum ferritin levels and transferrin saturation than nonathletes. Both acute and cumulative bouts of physical activity are known to induce an inflammatory response mediated by interleukin-6 (IL-6). 25 This increase in IL-6 can induce production of the iron-regulatory hormone hepcidin. Hepcidin internalizes and degrades the protein ferroportin, which transports iron out of the cell resulting in a lower bioavailability of iron. 25, 26 In this study we did not see an inflammatory response evaluated by the plasma hsCRP and nor did we see any changes in plasma hepcidin concentration after blood donation. Examining risk factors of developing iron deficiency being a blood donor might be the biggest risk factor of them all. In our study P-ferritin was still reduced by 45.2% (P-ferritin, 36 mg/L) 90 days after blood donation. In Denmark blood donors can donate blood at intervals of minimum 90 days. If they don't recover in P-ferritin from blood donation to blood donation they might end up becoming iron-deficient. A study by Garry and colleagues 27 found that women with low steady-state iron stores are only able to donate blood twice a year. In another study done by Milman and colleagues 24 focusing on women and iron status they found that women taking vitamin-minerals containing just 14 to 20 mg ferrous iron had an iron deficiency prevalence of 4.3% compared to 12.6% in those not taking any supplementation. In this study the women were asked not to take supplementation during the study, and it is thus likely that supplementation can augment the recovery of peak VO 2 and B-Hb concentration.
In conclusion, the major findings of this study were that 28 days was required after blood donation before peak VO 2 and B-Hb concentration were normalized. The prolonged recovery of B-Hb in these non-iron-deficient women is probably due to low P-ferritin, menstruation, and no iron supplementation in the study period. The TT performance was normalized already after 14 days, but given that peak VO 2 and B-Hb were only just recovered after 4 weeks we recommend that blood donation is not done within 5 weeks of participation in high-intensity competitions for iron-sufficient healthy women.
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